Socio-demographic correlates of late treatment initiation in a cohort of patients starting antiretroviral treatment in Mali, West Africa

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 23, Issue 11, 2011, Pages 1425-1429

  Pirkle, C M ^a   Nguyen, V K ^a,b   Aboubacrine, S Ag ^c   Cisse M ^d   Zunzunegui, M V ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b Clinique l'Actuel   (Canada)

^c Hôpital du Point G   (Mali)

^d CESAC   (Mali)

Author keywords

Access; Antiretroviral treatment; Gender; Late treatment initiation; West Africa

Indexed keywords

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; EDUCATION; FEMALE; GENDER; HEALTH CARE ACCESS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; MALI; MARRIAGE; PRIORITY JOURNAL;

ADULT; ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MALI; PATIENT ACCEPTANCE OF HEALTH CARE; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SOCIOECONOMIC FACTORS; TIME FACTORS;

EID: 84855708327     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540121.2011.565026     Document Type: Article

References (13)

1. Aday, L.A., & Andersen, R. (1974). A framework for the study of access to medical care. Health Services Research, 9(3), 208-220.
2. ART-LINC Collaboration of International Databases to Evaluate AIDS (IeDEA), Keiser, O., Anastos, K., Schechter, M., Balestre, E., Myer, L., ⋯ Egger, M. (2008). Antiretroviral therapy in resource-limited settings 1996 to 2006: Patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America. Tropical Medicine and International Health, 13(7), 870-879. (Pubitemid 351813514)
3. Bekker, L.G., Egger, M., & Wood, R. (2007). Early antiretroviral therapy mortality in resource-limited settings: What can we do about it? Current Opinion in HIV and AIDS, 2(4), 346-351. (Pubitemid 46941830)
4. Braitstein, P., Boulle, A., Nash, D., Brinkhof, M.W., Dabis, F., Laurent, C., ⋯ Bangsberg, D.R. (2008). Gender and the use of antiretroviral treatment in resource-constrained settings: Findings from a multicenter collaboration. Journal of Women's Health (Larchmt), 17(1), 47-55. (Pubitemid 351197536)
5. Braitstein, P., Brinkhof, M.W., Dabis, F., Schechter, M., Boulle, A., Miotti, P., ⋯ Egger, M. (2006). Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: Comparison between low-income and high-income countries. Lancet, 367(9513), 817-824. (Pubitemid 43363368)
6. Cellule de Planification et de Statistique Ministère de la Santé , Direction Nationale de la Statistique et de l'Informatique, Ministère du Plan et de l'Aménagement du Territoire, & ORC Macro International Inc. (2007). Enquête démographique de santé IV: Mali [Demographic health survey IV: Mali] (Rapport Pré - liminaire). Calverton, MD: MEASURE DHS, ICF Macro.
7. Hill, A., & Wood, E. (2007). Balancing effectiveness and access to HIV treatment in the developing world. AIDS, 21(3), 361-363. (Pubitemid 46175048)
8. Muula, A.S., Ngulube, T.J., Siziya, S., Makupe, C.M., Umar, E., Prozesky, H.W., ⋯ Mataya, R.H. (2007). Gender distribution of adult patients on highly active antiretroviral therapy (HAART)in Southern Africa: A systematic review. BMC Public Health, 7(1), 63-70.
9. Nattrass, N. (2008). Gender and access to antiretroviral treatment in South Africa. Feminist Economics, 14(4), 19-36.
10. Nicastri, E., Angeletti, C., Palmisano, L., Sarmati, L., Chiesi, A., Geraci, A., ⋯ Italian Antiretroviral Treatment Group. (2005). Gender differences in clinical progression of HIV-1-infected individuals during longterm highly active antiretroviral therapy. AIDS, 19(6), 577-583. (Pubitemid 40543980)
11. Prins, M., Robertson, J.R., Brettle, R.P., Aguado, I.H., Broers, B., Boufassa, F., ⋯ van den Hoek, A. (1999). Do gender differences in CD4 cell counts matter? AIDS, 13(17), 2361-2364.
12. Ruiz-Cantero, M.T., Vives-Cases, C., Artazcoz, L., Delgado, A., Calvente, M.dMG., Miqueo, C., ⋯ Valls, C. (2007). A framework to analyse gender bias in epidemiological research. J Epidemiol Community Health, 61(suppl II), ii46-ii53.3.
13. World Health Organization. (2006). Progress of global access to HIV antiretroviral therapy: A report on "3 by 5" and beyond. Retrieved June 2009, from http://www.who.int/hiv/fullreport-en-highres.pdf